P46360 2nd Annual Accelerating Clinical Trials in Asia 2018
Download Brochure Request

Register your interest


Register your interest


2nd Annual Accelerating Clinical Trials in Asia 2018

19-20 Sep 2018, One Farrer Hotel & Spa, Singapore

Book Now Download Brochure



The ONLY senior platform focused at clinical operational excellence Singapore, the Accelerating Clinical Trials in Asia zeroes in on the key operational and executional challenges in the burgeoning trial markets within Asia Pacific. Balanced with commercial information on Pharma spend areas and growth segments, this is your one stop shop to accelerate cost-efficient clinical development.

“Good networking opportunities with amazing people in the industry. This is my first conference and looking forward for more.”
Nur Farhana Muhamad, Market Analyst, Pharmaniaga Berhad

Snapshot of 2018 Attendee List:

View »

Conference Highlights

  • Global Pharma Spend areas – And plans for the Asian Clinical Trial market
  • Regional Government – Incentives, Investment, and Collaboration opportunities
  • KOL Engagement – And demonstrating value of Trial Protocols
  • Technology and Analytics – In practice, and how they are impacting trials
  • Compliance, Quality and Audits – Case studies and real world examples
  • Budgeting, Site Selection and Project Management – Working effectively with 3rd parties

Part of

Pharmacon Asia >>

Co-Located Events

Accelerating Clinical Trials in Asia >>
Pharma Regulatory Affairs Asia >>
Pharma Market Access and Pricing Summit Asia >>
Digital Pharma Summit >>


8:00 am

Registration and Networking Session


9:00 am

Addressing on skilled talent, strong manufacturing capabilities and thriving research ecosystem in pharmaceutical firms to set up to serve patients and connect with the growing Asian market.

9:30 am

[Industry Address] Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines

Nik Leist, Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

10:00 am

  • Drug pipeline growth areas
  • Regulatory trends
  • Innovation in pricing and market access
  • The most significant industry trends in the long term, and how should Pharma respond

10:40 am

Morning Networking and Refreshment Break

End of opening Plenary and 2nd Annual Clinical Trials in Asia Commence

11:10 am

Chairperson’s Opening Remarks


11:15 am

  • How are digital platforms shaping clinical trials operations?
  • How can we use digital platforms to improve and accelerate clinical trials?
  • Leveraging AI for a paradigm shift in clinical research
  • Patient engagement and the democratisation of clinical trial information
  • Cutting – edge technology to match the right patients with the right trials

11:45 am

  • Intelligent trials – the Road to successfully operating trials in digital platforms
  • Harnessing the power of data intelligence
  • Challenges and opportunities in clinical trials operations
  • Embracing change – organisation-wide and partner management
  • Future of clinical trials modernization in Asia

12:30 pm

Digitally Enabled Trials Should not be the Exception but the Norm

Senior Representative, IQVIA,

1:00 pm

Networking Lunch

2:00 pm

  • Enabling digital workflow throughout trial process
  • Improving patient enrollment and engagement
  • Smart decisions based on data-driven facts
  • Improving outcomes for patients and R&D


2:30 pm

  • What is “Investigator-led” oncology trials compared to the traditional pharma sponsored trials?
  • Examples of some of the “Investigator-led” oncology trials
  • Value of “Investigator-led” oncology trials for society

3:30 pm

Afternoon Networking and Refreshment Break

4:00 pm

  • Business case of approval and hospital permit highlights
  • Providing support / cooperation (funding, sponsored drugs/ medications)
  • Patient and subjects: Demography, Recruitment
  • The role of local coordinator: overcoming language and cultural barrier
  • Step by step approach in succeeding in Indonesia

4:30 pm

  • Challenges and opportunities for clinical research in Malaysia
  • Advantage in investigations, patient population, infrastructure
  • Facilities, infrastructure and personnel in healthcare system
  • Ethical concerns, approval process and regulations for clinical research
  • Clinical research leaders’ recruitment expertise
  • Optimizing patient recruitment
  • Best practices that can be used to ensure patients’ compliance
  • Best practices in selecting clinical research sites

5:30 pm

Chairperson’s Summary of the Day and End of Conference Day 1

9:00 am

Chairperson’s Opening Remarks


9:05 am

Japan- Pioneering Patient Centricity Initiative -Valuable Insights

Dr. Norie Miki-Yasuda, Head of Japan Clinical Operations Division. Janssen Pharmaceutical K.K., Japan

10:10 am

  • Framework of good practices for global project management
  • Managing external and internal teams
  • Stakeholder management through CROs
  • Overall outsourcing project Management

10:40 am

Morning Networking and Refreshment Break

11:10 am

CRO’s Perspective: Digitalisation Impact Areas – Trial Design, Patient Recruitment, Patient Centricity, Site Monitoring, Big Data Analytics, Cloud Based Clinical Data Warehouses

11:40 am

  • Conditional approval – an emerging as a paradigm to speed up drug development and accessibility to new critical treatments
  • Key merits and criticalities of this approach


12:10 pm

Moving Beyond Immuno-Oncology: a small molecule strategy

Harish Dave, Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

12:30 pm

Networking Lunch

1:30 pm

  • History of therapy (laser and injections)
  • Intravitreal and Subtenon delivery of medications (Triamcinolone, Bevacizumab, Aflibercept)
  • Anatomical and Functional Success
  • Our experience in conducting clinical trials

2:00 pm

Case Study in Infectious Disease Using Molecular Endpoints to Accelerate Clinical Trials through the Development of Molecular Endpoints

Raphael Zellweger, Scientific Director, The Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS)


2:30 pm

  • Opportunity and business expansion
  • Regulatory challenges and applications
  • Technology and site selection
  • Cost control and managing project
  • Case study

3:00 pm

  • Speeding up studies with eTMF Systems
  • Trial Management when TMF subcontracted to CRO
  • Organising TMF when the trial is multi-country or multi-centre
  • Trial data storage, security and quality

3:30 pm

Afternoon Networking and Refreshment Break


4:10 pm

  • Top line innovation trends and implications
  • Drug research and development environment in the long term
  • Impact of M&A activity and investment on industry
  • Emerging pharma business models, broadening value propositions, and sustainable revenue models

5:00 pm

Chairperson’s Summary of the Day and End of Conference


Packages Price
2 Day ConferenceSGD $2895Early Bird

Early Bird Rate: Register & Pay by 20 July 2018

Special 1-for-1 Offer on Normal Rates for Pharmaceutical Companies*
Limited seats, applicable only to 2-day main conference days.
Email register@ibcasia.com.sg to find out more!

*The organizer reserves the right to determine the industry to which your company belongs, and to stop the promotion at any stage.

Register 2 Delegates and get 1 FREE PASS
Register 3 Delegates and get 2 FREE PASS
(Group rate is based on normal rate of 2-day main conference package only)

For Group Registrations of more than 3 team members,
email info@ibcasia.com.sg or call +65 6508 2477

  • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>


Ho Weng Si

Director, Biomedical Sciences Group, Economic Development Board, Singapore

Nik Leist

Senior Director, Ingestible Sensor Manufacturing/Site Leader, Proteus Digital Health, USA

Enver Erkan

Country Manager, Pfizer Singapore

Alexis Serlin

Asia Cluster Head, Novartis

Miguel Angel Rivera Tapia

Global Digital Innovation Lead, Ferring Pharmaceuticals, Switzerland

Pablo Graiver

Co-founder & CEO, Antidote, United Kingdom

Clarence Khoo

Associate Director, Clinical Operations, Takeda Development Center (Asia)

Ajay Tiku

Region Medical Head, Asia Pacific, Middle East and Africa (APMA), Novartis

Dennis Teng

JAPAC Immunology Gastro TA Assoc. Director AbbVie, Singapore

Senior Representative, IQVIA

Fuqu Wang

Director, R&D Operations Innovation Leader, The Janssen Pharmaceutical, United States

Teoh Yee Leong

Chief Executive Officer, Singapore Clinical Research Institute

Hazel Dy Tioco

Asia Pacific Regional Director, Study Management and Logistics, Sanofi, Philippines

Dr. Martin Hertanto

Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

Tah Pei Chien

Principal Investigator, University Malaya Medical Centre, Malaysia

Naresh Gupta

M.D., Director- Professor, Maulana Azad Medical College, Chief, Haemophilia Centre &Network Coordinator for Haemophilia, India, Principal Investigator, Maulana Azad Medical College & Lok Nayak Hospital

Dr. Anggun Ramayudantha

Vitreoretina Specialist and Lecturer in Dept. of Ophthalmology, Faculty of Medicine Universitas Indonesia

Dr. Norie Miki-Yasuda

Head of Japan Clinical Operations Division. Janssen Pharmaceutical K.K., Japan

Alex Goh

Head, Regional Clinical Quality and Medical Quality, Asia Pacific, GSK, Singapore

Sow Wei Wong

Legal Counsel Takeda Global Research & Development Centre (Asia)

Yongho Oh

Regional Clinical PM and ISS PM for Asia, JPAC & China, Sanofi Pasteur, Singapore

Vincenzo Teneggi

Senior Medical Director, D3 (Drug Discover & Development) A*STAR, Singapore

Harish Dave

Co-Founder and Chief Medical Officer, Aum Biosciences, Singapore

Raphael Zellweger

Scientific Director, The Viral Research and Experimental Medicine Centre @ SingHealth Duke-NUS (ViREMiCS)

Yaron Turpaz

Chief Data & Technology Officer, Managing Director, Global Gene Corp, Singapore

when & where

19 - 20 Sep 2018

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com


Still have a question?

Speaking Opportunities
Sophia Zhao
+65-6508 2491

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489


Media & Association Partnership Opportunities
June Tan
+65 6508 2465




IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more